Domu vs Salient

For a no-code agency deploying and reselling voice AI, the two most critical factors are a no-code agent builder and white-labelwhite-label - Rebrand the product as your own to resell it to clients. sub-account support. Neither Domu nor Salient has published verified information on either of these attributes, so neither tool can be credited with an advantage on the features that matter most here. On production cost per minute and monthly platform fee, no verified figures exist for either tool. Both tools confirm native outbound campaigns, so that is a wash. Salient carries notably stronger funding credibility at Series A $60M backed by a16z versus Domu at seed stage, but funding alone does not decide a feature-driven use case. With the deciding features unverified for both tools, there is no factual basis to name a winner.

Both Domu and Salient support native outbound campaigns and hold SOC 2 Type IISOC 2 Type II - An independent audit confirming the vendor’s security controls operated effectively over a period of time. certification, covering the two most critical requirements for regulated collections outreach. On consent and recording compliance, Domu includes a verified HIPAA BAA on the base plan plus GDPR tooling, while Salient's equivalent compliance posture is not documented. Neither tool has published information on DTMF/IVR navigation or real per-minute production costs, leaving those factors unresolved. The compliance edge Domu shows is meaningful but not decisive without confirmation of Salient's gap.

For engineering teams building custom pipelines, API-first access is the foundation that everything else rests on. Salient explicitly confirms full lifecycle API access, while no corresponding confirmation exists for Domu. Both tools are early-stage startups, but Salient's Series A of $60M backed by a16z at a $350M valuation signals a more mature engineering organization and roadmap compared to Domu's seed-stage YC S24 funding, which matters when betting a production pipeline on a platform. Neither tool has published information on bring-your-own LLMBYO LLM - Bring your own language model - use an OpenAI, Anthropic, or self-hosted endpoint instead of the platform default., latency, bring-your-own TTS voice, SIP trunking, or a simulation and testing suite, so those factors cannot differentiate the two. The one attribute that is directly confirmed and most critical for this use case breaks in Salient's favor.

For ecommerce support and order flows, the most critical factors are native integrations, built-in knowledge base, monthly platform fee, and self-serve signup. Neither Domu nor Salient publishes information covering native integrations count, built-in knowledge base, or monthly platform fee. On self-serve signup, both tools require a sales process rather than instant signup. With no differentiating information available on any of the top deciding factors, and both tools matching on self-serve signup status, there is no basis to favor one over the other.

For HIPAAHIPAA BAA - A signed Business Associate Agreement that lets you handle protected health information under US healthcare privacy law.-bound healthcare workflows, the single most critical requirement is a HIPAA Business Associate Agreement, and Domu includes one on the base plan. No equivalent fact is published for Salient, meaning healthcare teams would face real compliance uncertainty before signing with Salient. Both tools hold SOC 2 Type II certification, so that criterion is even. Domu also confirms GDPR tooling and EU residency support, adding another compliance layer that matters to healthcare organizations with international operations. On the credibility side, Salient has a stronger funding position (Series A at $60M backed by a16z versus Domu's seed-stage YC S24 round), but financial backing does not substitute for documented compliance coverage when patient data is at stake.

Both tools support native outbound campaigns, so that capability is a draw. The deciding factor becomes credibility and scale for production call-center operations. Salient has raised a $60M Series A led by a16z at a $350M valuation, signaling the engineering and operational depth needed for high-volume outbound workloads. Domu, founded in 2024 with only seed-stage YC funding, is earlier stage and less proven for large-scale campaigns. Production cost per minute, concurrencyconcurrency - How many phone calls the platform can handle at the same time. limits, SIP trunking, and warm transfer data are unpublished for both tools, so those attributes cannot separate them. Salient's stronger funding and longer track record tip the scales.

For an SMB receptionist and booking use case, the platform fee is the most critical buying factor, yet neither Domu nor Salient publishes a monthly platform price. The same gap applies to built-in knowledge base, no-code agent builder, warm transferwarm transfer - Handing a live call to a human with context passed along, rather than a cold drop., and number provisioning: none of these attributes are reported for either tool. With the deciding factors all unresolved, the comparison cannot favor one tool over the other. Salient does carry stronger credibility signals, with a Series A of $60M backed by a16z versus Domu's early Seed stage from YC S24, but credibility alone does not determine fit when the functional and pricing attributes that matter most are simply not on record.